Airway epithelial cells are the principal host cells for respiratory virus infection and play an important role in initiating the immune response to virus. Virus-infected epithelial cells secrete cytokines (e.g., GM-CSF and interleukin [IL]-11) and chemokines (e.g., regulated on activation, normal T cells expressed and secreted [RANTES] and IL-8) that can then recruit and activate inflammatory cells (1) (2) (3) (4) . Chemokine secretion by airway epithelial cells may be a key event both in innate and acquired immune responses to viral infections. For example, RANTES is a potent chemoattractant for monocytes, NK cells, CD4/CD45RO T cells, eosinophils, and basophils(5-7), whereas IL-8 is one of the principal signals to recruit neutrophils into the airway (8) . Through these effects, chemokine secretion has also been linked to the pathogenesis of virus-induced airway inflammation and asthma (9) (10) (11) .
The interaction of respiratory viruses and epithelial cells can be modulated by cytokines that are secreted by mononuclear cells. For example, tumor necrosis factor (TNF)-␣ , which is secreted by macrophages in response to rhinovirus (RV) (12) , can induce intercellular adhesion molecule (ICAM)-1 expression, and perhaps through this action can decrease the infectious inocula needed to establish a productive RV infection in vitro (1) . Furthermore, interferon (IFN)-␥ , which is secreted by lymphocytes in response to RV, is also a potent inducer of ICAM-1 on a variety of cell types (13, 14) . Therefore, cytokine induction of ICAM-1 may have dual effects during RV infections: increased ICAM-1 expression could enhance recruitment of inflammatory cells into the airway, and thereby help to initiate antiviral immune responses in the airway. However, because ICAM-1 is the receptor used by major group RV (15, 16) , virus binding to host cells could also be increased, thus potentiating damage to airway epithelial cells.
Although the effects of IFN-␥ and TNF-␣ on epithelial cells are complex, their effects on ICAM-1, and independent effects on chemokine production, suggest that these cytokines might be important regulators of RV-induced epithelial cell activation. To evaluate this hypothesis, the effects of IFN-␥ and TNF-␣ on epithelial cell ICAM-1, RV binding, and RV-induced epithelial cell secretion of the chemokines RANTES and IL-8 were determined with A549 cells, a type 2 alveolar epithelial cell line, and with nontransformed cultures of human bronchial epithelial cells (HBEC).
Materials and Methods

Cell Culture
HBEC for primary culture were isolated from surgical specimens of normal human bronchi or trachea (lung transplant donors) as previously described (2) . All primary cell cultures were grown in serum-free, hormonally-supplemented medium (Bronchial Epithelial Cell Growth Medium [BEGM] ; Clonetics, San Diego, CA), and were passaged up to four times. Cell viability, as assessed by exclusion of trypan blue dye, was consistently greater than 90%.
A549 cells obtained from American Type Culture Collection (CCL 185; Rockville, MD) were grown in Kaign's nutrient mixture F-12 medium (Irvine Scientific, Santa Ana, CA) supplemented with 10% fetal calf serum (FCS; Hyclone, Logan, UT), 2 mM L -glutamine, 100 U/ml penicillin, 100 g/ml streptomicin, and 20 g/ml gentamycin at 37 Њ C and 5% CO 2 . The Ohio strain HeLa cells were maintained in shake cultures in medium B (17) . Recombinant human IFN-␥ and TNF-␣ were purchased from Promega, Inc. (Madison, WI).
Virus Suspensions
RV16, RV49, and type III parainfluenza virus (PIV III) were grown in the Ohio strain of HeLa cells. Culture medium with HeLa cells was inoculated with virus and grown in rolling bottles at 33 Њ C.
Growth was allowed to continue until cytopathic effects were well advanced. The resulting fluids were centrifuged (2,000 rpm, 30 min, 20 Њ C) to remove cellular debris. The virus suspensions were then purified by centrifugation over a sucrose gradient (17) . Aliquots of virus with infectivity of 10 7 -10 10 tissue culture infectious dose 50 (TCID 50 )/ml, as measured by inoculating serial dilutions of virus suspension in HeLa (RV16) or WI-38 (RV49) cells, were stored at Ϫ 70 Њ C until needed.
Radiolabeled RV16 and RV49 were prepared by infecting HeLa cells (4.0 ϫ 10 7 cell/ml) with 10-15 plaque-forming units (PFU) /cell in phosphate-buffered saline (PBS). One hour later, infected cells were diluted 10-to 15-fold in growth medium lacking all amino acids except glutamine and supplemented with 25 mM HEPES and 5 g/ml actinomycin D, and incubated at room temperature. Four hours after inoculation, 35 S-methionine (1 mCi/1.8 ϫ 10 8 cells) was added and the cells were incubated for an additional 3 h. The cells were then pelleted and resuspended in growth medium. The cells were lysed in Nonidet P-40 (0.5%, Sigma-Aldrich, St. Louis, MO) at room temperature. Cell debris was removed by centrifugation (12 min, 15,000 rpm) in a Sorvall SS34 rotor (Kendro Laboratory Products, Newtown, CT), and the supernatant was treated with RNase A and EDTA at room temperature, layered over a series of 10, 20 and 30% sucrose layers, and then centrifuged (15 Њ C, 90 min, 45,000 rpm, 55T rotor, Beckman Coulter, Fullerton, CA). After decanting, the pellet was resuspended, aliquoted and stored at Ϫ 80 Њ C.
Generation of Infectious RV16 RNA
To produce a large quantity of infectious viral RNA, a full-length RV16 cDNA plasmid, pR16.11, was used as template for in vitro transcription. The pR16.11 was constructed by cloning the RV16 duplex cDNA fragments used for sequencing (18) into a plasmid vector. To generate infectious RV16 RNA, the plasmid was linearized by incubation (37 Њ C, 3 h) of 10 g of pR16.11 with 20 U of SacI (New England Biolabs, Beverly, MA) in a total volume of 40 l. RV16 RNA was synthesized by incubating (37 Њ C, 1 h) 8 l of plasmid digest with 8 l 5 ϫ buffer (Life Technologies, Rockville, MD), 32 U RNase inhibitor (Promega), 0.56 mM rNTPs (Promega), and 50 U T7 RNA polymerase in a total volume of 40 l. The transcripts were extracted from the mixture using a phenol/chloroform reagent (RNA Stat-60; Leedo Medical Laboratories, Houston, TX) and precipitated twice in 2 vol 100% ethanol and 1/10 vol 3 M sodium acetate (pH 5.2). The RV16 RNA transcripts were quantitated by comparison to dilution of an RNA (Life Technologies) standard on a 1% agarose gel stained in ethidium bromide.
Inoculation of HBEC with RV
HBEC were grown in 24-well plates with BEGM to near confluence. Twenty-four hours before viral inoculation, the medium was changed to BEGM without hydrocortisone, epidermal growth factor, epinephrine, or bovine pituitary extract, to remove factors that could potentially affect cytokine production. The monolayers were then inoculated with either RV16, RV49, or PIV III, with or without indicated reagents, and incubated for 24 h (mRNA) or 48 h (protein) at 37 Њ C and 5% CO 2 . The culture supernatants and the infected cells were then collected for enzyme-linked immunosorbent assay (ELISA) and RT-PCR, respectively.
Transfection of Epithelial Cells with RV16 RNA
For transfections, A549 cells were plated at 1-2 ϫ 10 5 cells/well in six-well tissue culture plates and allowed to grow to 80% confluence ( ‫ف‬ 48 h). The cells were then incubated (37 Њ C, 5 h) with 8 l LipofectAMINE reagent (Life Technologies) and either RV16 RNA (0.005-0.5 g), or RNA isolated from the yeast Blastomycetes (Bruce Klein, University of Wisconsin-Madison). Five hours following the start of transfection, the medium containing the transfection complexes was removed and replaced with 2 ml fresh medium as described above. Twenty-four hours later, the cells were harvested for RNA and/or luciferase activity, and supernatants were collected and stored at Ϫ 80 Њ C pending analysis for RANTES protein.
Transfection efficiencies were monitored by cotransfecting with a plasmid (pGL2) containing the luciferase gene (Promega), and then analyzing luciferase activity in cell lysates with luminometer (Analytical Luminescence, Ann Arbor, MI). Preliminary experiments showed no significant changes in luciferase expression when pGL2 was cotransfected with transfection reagent containing 0-2 g/ml RV RNA.
Whole Cell ELISA Assay for ICAM-1 Expression
Epithelial cell ICAM-1 expression was measured with a semiquantitative whole-cell ELISA, as previously described (2) . Briefly, HBEC monolayers were cultured (48 h, 96-well plates) with or without IFN-␥ (0.1, 1, or 10 U/ml) or TNF-␣ (10 or 100 U/ml), washed, and then incubated (2 h) in blocking solution with anti-ICAM-1 monoclonal Ab (RR1; a gift from Robert Rothlein, Boehringer Ingelheim, Ridgefield, CT) or isotype control antibody (mouse IgG 1 ; Sigma Chemical Co.). After washing, the ELISA was developed using horseradish peroxidase-conjugated sheep anti-mouse IgG 1 Ab (Sigma Chemical Co.) and 3,3 Ј ,5,5 Ј -tetramethylbenzidine. The data are reported as mean values absorbance (@ 450 nm) from three wells. The coefficient of variation was generally less than 10%.
RV Binding Assay
Monolayers ( ‫ف‬ 80% confluent) of A549 cells or HBEC in 12-well plates were incubated with either IFN-␥ (10 U/ml), TNF-␣ (100 U/ml), or medium alone for 24 h. Preliminary experiments had established that these concentrations of cytokines produced maximum ICAM-1 expression without causing cytopathic effects. After incubation, cells were washed once with PBS, overlayed with 0.5 ml PBS containing 0.1% human serum albumin, and then anti-ICAM-1 mAb (final concentration 20 g/ml), anti-low density lipoprotein receptor (LDLR) mAb (final concentration 100 g/ml) or mouse isotype control (IgG2b; PharMingen, San Diego, CA) were added to the wells. The plates were rotated at room temperature for 1 h, and either 35 S-methionine-labeled RV16 (1,000 particles/cell) or 35 S-methionine-labeled RV49 (100 particles/cell) was added to the wells and incubated at room temperature for a further 2 h. Lower concentrations of RV49 were used because of the lower titers of this virus preparation. The supernatant was sampled for scintillation counting, and unbound virus was removed. The cells were washed twice with 1 ml/well of PBS lacking divalent cations and the cells removed by trypsinization. The trypsinized cells were mixed well and sampled for scintillation counting. Scintillation samples were counted in Bio-Safe scintillation fluid (Research Products International Corp, Mount Prospect, IL).
RV16 Replication Assay
When monolayers of HBEC in 24-well plates with BEGM were near confluence, medium (BEGM without hydrocortisone, epidermal growth factor, epinephrine, and bovine pituitary extract) was applied along with either IFN-␣ (500 U/ml), IFN-␥ (10 U/ml), or TNF-␣ (100 U/ml). After incubation (24 h, 37 Њ C, 5% CO 2 ), the cells were inoculated with RV16 (10 7 TCID 50 /ml), and incubated at room temperature for 90 min on rotating plate. The cells were washed to remove unbound virus, and incubated (35 Њ C, 5% CO 2 ) in fresh medium and cytokine, and this was verified by performing viral titers 2 h after inoculation and after washing. Twentyfour hours after inoculation, the cell suspensions were subjected to three freeze/thaw cycles to release intracellular virus to mea-sure viral yield. The suspensions were collected, centrifuged to remove cellular debris, and the supernates were collected and stored at Ϫ 70 Њ C pending quantitative viral cultures, as previously described (12) . All samples were performed in duplicate, and viral titers were expressed as log (TCID 50 units/ml).
Chemokine ELISA
RANTES and IL-8 protein in culture supernatants were measured using sandwich ELISA (2) with the following materials and reagents: capture antibodies, murine anti-human RANTES monoclonal Ab (MAB278; R&D Systems, Minneapolis, MN) or murine anti-human IL-8 monoclonal Ab (MAB208; R&D Systems); detection antibodies, biotinylated goat anti-human RANTES polyclonal Ab (BAF278; R&D Systems) or biotinylated goat anti-human IL-8 polyclonal Ab (BAF205; R&D Systems); recombinant human RANTES (Biosource, Camarillo, CA), recombinant human IL-8 (208-IL; R&D Systems), horseradish-streptavidin peroxidase conjugate (Zymed Laboratories, South San Francisco, CA), and 3,3 Ј ,5,5 Ј -tetramethylbenzidine (Kirkegaard and Perry, Gaithersburg, MD). The samples were assayed in duplicate, and the results expressed in pg/ml. The sensitivity of both the RANTES and IL-8 assays was 3-6 pg/ml and the coefficient of variation was generally less than 3%.
Detection of RANTES mRNA with Semiquantitative RT-PCR
RANTES mRNA in bronchial epithelial cells was analyzed with semiquantitative RT-PCR as previously described (2) . The number of cycles (33 cycles for RANTES, 24 cycles for G3PDH) of PCR was chosen to maintain a linear relationship between mRNA and the PCR products so that quantitative comparisons of PCR products could be obtained. A reference standard curve consisting of serial 4-fold dilutions of RANTES or G3PDH cDNA template was included in each PCR run. Each PCR run also included negative control sample containing all PCR reagents but no cDNA. G3PDH cDNA was amplified to provide a control for the amount of total RNA in each sample. Southern blotting for RANTES and G3PDH was performed, and the blot image was scanned (Scanjet II P; Hewlett Packard, Greeley, CO) to convert it into a digital image, and mRNA was quantitated by comparing the standard curves of the blot densities of the hybridized PCR products from serial diluted cDNA templates with the aid of computer software (Sigmagel; Jandel Scientific, San Rafael, CA).
Data Analysis
The effects of cytokines on epithelial receptor expression or RV binding was evaluated by ANOVA, and multiple pairwise comparisons were performed with the Bonferroni t test. Treatmentrelated differences in RANTES protein were evaluated with ANOVA, and Fisher test was used for pairwise comparisons between variables. RANTES mRNA expression data were not normally distributed and were analyzed by ANOVA on ranks. Values for RANTES secretion after transfection in Table 1 were logtransformed to approximate a normal distribution, and were analyzed by three-way ANOVA (factors evaluated were cytokine pretreatment, experiment no., and the dose of poly IC). All calculations were performed with the aid of either Stat View II (Abacus Concepts, Inc., Berkeley, CA) or SigmaStat (SPSS Inc., Chicago, IL) computer software. A P value less than 0.05 was considered significant.
Results
Effects of IFN-␥ versus TNF-␣ on ICAM-1 Expression
To compare the effects of IFN-␥ and TNF-␣ on ICAM-1 expression by HBEC or A549 cells, cell monolayers were incubated with either IFN-␥ (0.1-10 U/ml), TNF-␣ (10-1,000 U/ml), or medium alone for 48 h, and ICAM-1 expression was measured by whole cell ELISA. On HBEC, ICAM-1 expression was induced by IFN-␥ in a dose-dependent manner, whereas TNF-␣ caused relatively small, but statistically significant increases in ICAM-1 expression ( Figure  1A ). In contrast to experiments conducted with HBEC, TNF-␣ was a more potent than IFN-␥ in stimulating ICAM-1 expression on A549 cells ( Figure 1B) . Preliminary experiments had shown that higher doses of either cytokine produced cytopathic effects on HBEC.
Effects of IFN-␥ on RV Binding to A549 Cells
To confirm that IFN-␥-induced increases in ICAM-1 would enhance RV binding, the effects of IFN-␥ on binding of major and minor group RV to airway epithelial cells were measured. Either HBEC or A549 cells were incubated either with IFN-␥ (10 U/ml), TNF-␣ (100 U/ml), or medium alone, and then 35 S-methionine-RV for 2 h with or without anti-ICAM monoclonal Ab, anti-LDLR monoclonal Ab (C7) or isotype control Ab. Relatively small amounts of the major-group virus RV16 bound to untreated epithelial cells, and blocking antibody had no detectable effect on viral binding (Figures 2A and 2B) . IFN-␥ enhanced binding of RV16 to either HBEC (Figure 2A ) or A549 cells (Figure 2B) , and this binding was blocked by mAb specific for ICAM-1 (Figures 2A and 2B) . In contrast to effects of IFN-␥, TNF-␣ greatly enhanced RV16 binding to A549, but had a relatively small effect on binding to HBEC (Figures  2A and 2B ).
There was a distinct pattern of binding of the minor group virus RV49 to HBEC ( Figure 2C ). Binding of RV49 to HBEC cells was relatively high in cells incubated in medium alone, and was significantly blocked by C7 mAb ( Figure 2C ). Specific RV49 binding to HBEC in the presence of either IFN-␥ or TNF-␣ remained high, but was unchanged compared with cells incubated in medium alone.
Effects of Cytokines on RV16 Replication
To determine whether cytokines could affect RV16 replication, replication of RV16 in HBEC or A549 cells was determined in the presence or absence of IFN-␥ (10 U/ml), TNF-␣ (100 U/ml), or IFN-␣ (500 U/ml). Cytokine pretreatment had no significant effect on the amount of virus associated with HBEC (3.34 Ϯ 0.54 TCID 50 /ml) or A549 cells (2.13 Ϯ 0.89 TCID 50 /ml) after inoculation with RV16 followed by washing (mean Ϯ SD, P ϭ NS, ANOVA). In contrast, evaluation of quantitative viral cultures 24 h after inoculation demonstrated that IFN-␣ significantly suppressed the viral yield in HBEC ( Figure 3A) , and similar trends were noted in A549 cells ( Figure 3B ). Neither IFN-␥ nor TNF-␣ significantly affected the viral yield in either type of epithelial cell.
Effects of Cytokines on RV16-Induced RANTES Secretion
The effects of TNF-␣ (100 U/ml) and IFN-␥ (10 U/ml) on RANTES secretion were determined in HBEC or A549 cells in the presence or absence of RV16 (10 7 TCID 50 /ml). IFN-␥ alone was a relatively weak inducer of RANTES in either cell type, but enhanced RV16-induced RANTES secretion ( Figures 4A and 4B ). TNF-␣ alone had different effects on the two different cell types: by itself, it had little effect on HBEC RANTES secretion ( Figure 4A ), but was a potent inducer of RANTES in A549 cells ( Figure 4B ). In contrast to IFN-␥, however, TNF-␣ did not enhance RV16-induced RANTES secretion in either cell type.
These experiments were broadened to evaluate potential synergy between IFN-␥ and RV49, a minor-group rhinovirus that binds to the LDLR instead of ICAM-1, in stimulating secretion of RANTES and IL-8. HBEC were incubated (48 h) with RV16 (10 7 TCID 50 /ml) or RV49 (10 6 TCID 50 /ml) in the presence or absence of IFN-␥ (10 U/ml). Inoculation with either RV16 or RV49 alone (48 h) induced low levels of RANTES secretion from HBEC, and this was significantly enhanced by coincubation with IFN-␥ ( Figure 5A ). A different pattern of IL-8 secretion was observed, however, in that unstimulated cells secreted relatively high amounts of IL-8, and this tended to be enhanced by RV16 or RV49. In contrast to effects on RANTES, however, IFN-␥ did not enhance virus-induced IL-8 ( Figure 5B ). The synergistic effects between RV16 and IFN-␥ on RANTES production were also demonstrated at the level of RANTES mRNA expression. Inoculation with RV16 or RV49 (24 h) induced low level expression of RANTES mRNA after 24 h ( Figure 5C ). Coincubation with IFN-␥ enhanced RV16-induced expression of RANTES, and similar trends were observed in experiments conducted with RV49 ( Figures 5C and 5D) .
To test whether IFN-␥ could boost RANTES production stimulated by viruses other than RV, effects of PIV III on RANTES secretion were determined in the presence or absence of either IFN-␥ (10 U/ml) or TNF-␣ (100 U/ml). Although PIV III (10 5 or 10 6 TCID 50 /ml) alone was a potent stimulus of RANTES secretion, neither IFN-␥ nor TNF-␣ significantly affected PIV-induced RANTES production by HBEC (Figure 6 ).
Effects of IFN-␥ on RANTES Secretion by A549 Cells
Transfected with RV16 RNA To determine whether IFN-␥ effects on RV-induced RANTES production were independent of changes in the number of surface receptors, infectious RV16 RNA was transfected into A549 cells in the presence or absence of IFN-␥. Transfected RV RNA (0.5 g/well) alone stimulated RANTES secretion in A549 cells in a time-dependent manner, but relatively little RANTES was secreted by cells that were transfected with yeast RNA ( Figure  7A ). Incubation of transfected cells with IFN-␥ (10 U/ml) caused a small additional increase in RANTES secretion ( Figure 7A ).
To determine whether effects of IFN-␥ depends on the quantity of intracellular RV RNA, A549 cells were transfected with 0.005-0.5 g/well of RV16 RNA in the presence or absence of IFN-␥ (10 U/ml). IFN-␥ enhanced RANTES secretion after transfection of small amounts (0.005-0.05 g/well) of RV16 RNA, but had less effect when cells were transfected with 0.5 g/well of RV16 RNA ( Figure 7B) .
Transfection of A549 cells with RV16 RNA caused new synthesis of infectious RV16 particles (10 0.5 -10 2 TCID 50 /ml). To exclude the potentially confounding effects of newlysynthesized viral particles binding to surface ICAM-1, these experiments were repeated in the presence or absence of monoclonal Ab (RR1) to block RV attachment to ICAM-1. Although the anti-ICAM-1 Ab tended to reduce the amount of secreted RANTES, IFN-␥ (10 U/ml) and RV16 RNA (0.005 g/well) acted synergistically to induce RANTES secretion even in the presence of anti-ICAM-1 mAb ( Figure 7C ).
Synergistic Effects of Double-Stranded RNA (dsRNA) and IFN-␥ on RANTES Secretion
Double-stranded RNA is formed during RV replication (19) , and can activate epithelial cells and fibroblasts to secrete cytokines such as IFN-␤ and IL-6 (20) . To investigate potential mechanisms for the upregulation of RANTES secretion by RV and IFN-␥, HBEC were either transfected with synthetic dsRNA (poly IC, 1-100 ng/ml) or synthetic single-stranded RNA (ssRNA, poly U, 1-100 ng/ml), or were mock transfected. The samples were next incubated (24 h, 37ЊC) with IFN-␥ (10 U/ml), TNF-␣ (100 U/ml), or medium alone, and RANTES secretion was determined. Transfection of poly IC alone induced RANTES secretion in a dose-dependent fashion, whereas IFN-␥ or TNF-␣ alone induced low levels of RANTES ( Table 1 ). The combination of dsRNA transfection and IFN-␥ incubation synergistically enhanced RANTES secretion (P Ͻ 0.05). TNF-␣ also boosted dsRNA-induced RANTES (P Ͻ 0.05 versus control), although to a lesser extent than IFN-␥ (P Ͻ 0.05). Transfection of the ssRNA analog poly U, or mock transfection, elicited little or no RANTES secretion (Ͻ 15 pg/ml, data not shown).
Discussion
Epithelial cell-derived chemokines such as RANTES contribute to the initiation of the immune response to viral infections, and our studies suggest that in the case of RV, IFN-␥ may be an important regulator of this process. Specifically, our studies demonstrate that IFN-␥ can synergistically enhance RANTES mRNA and protein secretion from RV16 (major serotype RV)-or RV49 (minor serotype RV)-infected HBEC. These studies provide evidence of two distinct mechanisms for the effects of IFN-␥. First, IFN-␥ can induce cellular receptors, i.e., ICAM-1 and LDLR, used by RV to gain entry into the host epithelial cell, and increasing the amount of receptor-mediated RV binding was associated with increased RANTES secretion. Second, these experiments provide several lines of evidence that IFN-␥ can also enhance RV-induced RANTES secretion independent of effects on viral receptors. Finally, because IFN-␥ promoted virus-induced RANTES, but not IL-8, this effect may be an important mechanism by which mononuclear cells can modulate epithelial cell responses to viral infection.
IFN-␥ could potentiate responses to major-group RV by enhancing expression of ICAM-1. Accordingly, our experiments confirmed previous observations to indicate that IFN-␥ is more potent than TNF-␣ as an inducer of ICAM-1 on nontransformed human airway epithelial cells. The comparative effects of TNF-␣ and IFN-␥ on HBEC ICAM-1 expression mirrored effects of these cytokines on RV-induced RANTES secretion: these data suggest the possibility of a causal relationship whereby IFN-␥ enhances RV-induced RANTES secretion by increasing viral binding to HBEC.
In addition to enhancing ICAM-1 expression and RV binding to airway epithelial cells, several lines of evidence indicate that IFN-␥ can promote RV-induced RANTES through a receptor-independent mechanism. First, TNF-␣ did not augment RV-induced RANTES secretion in either HBEC or A549 cells, despite the fact that TNF-␣ induced ICAM-1 expression, particularly on A549 cells.
Further evidence of an intracellular effect of IFN-␥ was provided by experiments conducted with the minor group RV49. Binding of RV49 to HBEC was high in cells incubated in medium alone, and there was no further enhancement by either IFN-␥ or TNF-␣. This finding is consistent with the finding that RV49 also induces greater cytopathology in HBEC compared with RV16 (2). The binding was blocked by C7 mAb, indicating that the virus bound to the LDLR, as is expected with a minor group RV. Our HBEC monolayers were grown in serum-free medium in vitro, and studies in hepatocytes suggest that growing cells in the absence of serum induces the expression of LDLR (21) . Studies using bronchoscopy and bronchial lavage suggest that HBEC are also exposed to low concentrations of serum proteins in vivo, because bronchial secretions normally contain very little serum proteins such as IgG or albumin. The fact that IFN-␥ augments RV49-induced RANTES secretion without affecting viral binding further supports the concept that IFN-␥ can augment RV-induced RANTES production independent of effects on receptor expression. Finally, additional evidence for receptor-independent augmentation of RV-induced RANTES was provided by experiments in which RV RNA was transfected into cells without viral binding to cell surface receptors. For example, IFN-␥ boosted RANTES secretion even when infectious RV RNA was transfected into epithelial cells, thus bypassing engagement of cellular receptors. This effect was independent of the binding of newly-synthesized viral particles to receptors on the cell surface, as demonstrated by performing the same experiment in the presence of blocking anti-ICAM-1 mAb.
IFN-␥ enhanced RANTES secretion after transfection of low doses of RV RNA, but had less effect when the cells were transfected with large doses (0.5 g) of RV RNA. One possible explanation for this effect is that RV RNA-induced RANTES production may depend on activation of double-stranded RNA-dependent protein kinase (PKR) (22) as it has recently been demonstrated that RV can activate PKR in B cells (23) . The dose response curve for PKR activation by dsRNA is bell-shaped (24) , and this pattern is similar to the dose-response curve of RV RNAinduced RANTES secretion.
Our experiments support the concept that generation of dsRNA during RANTES replication may be an important factor in RV-induced RANTES production, in that transfection of poly IC was a potent stimulus for RANTES. Moreover, IFN-␥ enhanced dsRNA-induced RANTES secretion, suggesting a possible intracellular mechanism for this effect. This finding suggests that IFN-␥ and RV, or RV dsRNA, may activate signal transduction pathways that are complementary in their ability to activate RANTES gene transcription. In support of this hypothesis, RV infection causes nuclear factor-B (NF-B) activation (3), and the RANTES gene promoter contains four potential binding sites for NF-B (25, 26) , as well as several IFN-␥-activated sites (TTNCNNNAA) (25, 27) . Complementary effects of IFN-␥ could include either induction of additional transcription factors (e.g., STAT-1) that enhance RANTES promoter activity, or stabilization of RANTES mRNA stability (28) . We are now conducting additional experiments to test these hypotheses.
The effect of IFN-␥ on virus-induced RANTES generation appears to vary with the type of virus. It has previously been reported that IFN-␥ enhances RSV-induced RANTES (29), but we did not find IFN-␥ to enhance PIVinduced RANTES secretion. This finding, plus the fact that PIV alone was a better inducer of RANTES compared with RV, suggests that these different single-stranded RNA viruses activate distinct intracellular signaling pathways. Moreover, the lack of synergism with IFN-␥ suggests that mechanisms used by PIV and IFN-␥ to enhance RANTES production may overlap.
In conclusion, these in vitro experiments demonstrate that IFN-␥ is a potent positive regulator of RANTES secretion by RV-infected airway epithelial cells. This finding suggests that the secretion of IFN-␥ by T cells and NK cells within airway tissues during the early stages of RV infection could regulate interactions between viral particles and host epithelial cells, and subsequent secretion of RANTES. These findings suggest that IFN-␥ may have a dual role in the immune response to infections with RV and perhaps other respiratory viruses. First, studies in animals (30) and in humans (31) indicate that strong IFN-␥ responses are associated with an effective antiviral response. On the other hand, because RANTES is a potent chemoattractant for memory T cells, monocytes, eosinophils, and basophils, augmentation of RANTES secretion in vivo could enhance airway inflammation and promote airway obstruction, and this may be of particular significance in patients with asthma. Further understanding of this pathway could lead to new insights into the pathogenesis of RV-induced inflammation during common colds and virus-induced exacerbations of asthma.
